Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $48,674 - $57,936
426 Added 13.19%
3,656 $449,000
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $160,918 - $191,663
1,319 Added 69.02%
3,230 $418,000
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $66,517 - $79,907
543 Added 39.69%
1,911 $236,000
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $183,284 - $219,522
1,368 New
1,368 $200,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.